Fredrik Ildstad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fredrik Ildstad has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Bent Indredavik
Norwegian University of Science and Technology
4 shared publications - Stian Lydersen
Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway
4 shared publications - Hanne Ellekjær
Norwegian University of Science and Technology
3 shared publications - Torgeir Wethal
Department of Neuro Medicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
3 shared publications - Hild Fjærtoft
Norwegian University of Science and Technology
2 shared publications - Agnethe Eltoft
Department of Clinical Medicine, Faculty of Health Sciences UiT the Arctic University Tromsø Norway
1 shared publication
Latest Publications
- Open Access
- 13 August 2026
- Published by SAGE Publications in Clinical Rehabilitation
Fatigue after ischaemic stroke: A five-year longitudinal study of prevalence and latent trajectory subgroups
Objective: To investigate the prevalence and longitudinal course of post-stroke fatigue and identify subgroups with distinct fatigue trajectories up to 5 years post-stroke. Design: A prospective, longitudinal, multi-centre cohort study. Setting: Hospital stroke units in the Central-Norway health region. Participants: Incident ischaemic stroke patients were recruited during acute hospitalisation between June 2015 and November 2017. Data were collected during the hospital stay and at 3 months, 1 year, 3 years, and 5 years. Main measures: Fatigue was assessed using the 7-item Fatigue Severity Scale with > 5 as cut-off to define clinical fatigue. Results: A total of 693 participants were included. The prevalence of clinical fatigue was 24% (3 months), 28% (1 year), 30% (3 years), and 28% (5 years). A Sankey diagram illustrated substantial variability in fatigue status across time points. Using group-based trajectory modelling, four latent subgroups with distinct fatigue trajectories were identified: (1) low fatigue, (2) emerging fatigue, (3) improving fatigue, and (4) high fatigue. Conclusion: One quarter to one third of the study population consistently exhibited fatigue up to 5 years post-stroke. High variability in fatigue status over time was evident, indicating individual-level heterogeneity in the longitudinal course. This was further confirmed by the identification of four latent subgroups with distinct post-stroke fatigue trajectories. Early detection of individuals at risk of an adverse fatigue trajectory and differentiated follow-up may improve outcomes for stroke survivors.
- 13 August 2026
- Published by SAGE Publications in Clinical Rehabilitation
Open AccessFatigue after ischaemic stroke: A five-year longitudinal study of prevalence and latent trajectory subgroups
Objective: To investigate the prevalence and longitudinal course of post-stroke fatigue and identify subgroups with distinct fatigue trajectories up to 5 years post-stroke. Design: A prospective, longitudinal, multi-centre cohort study. Setting: Hospital stroke units in the Central-Norway health region. Participants: Incident ischaemic stroke patients were recruited during acute hospitalisation between June 2015 and November 2017. Data were collected during the hospital stay and at 3 months, 1 year, 3 years, and 5 years. Main measures: Fatigue was assessed using the 7-item Fatigue Severity Scale with > 5 as cut-off to define clinical fatigue. Results: A total of 693 participants were included. The prevalence of clinical fatigue was 24% (3 months), 28% (1 year), 30% (3 years), and 28% (5 years). A Sankey diagram illustrated substantial variability in fatigue status across time points. Using group-based trajectory modelling, four latent subgroups with distinct fatigue trajectories were identified: (1) low fatigue, (2) emerging fatigue, (3) improving fatigue, and (4) high fatigue. Conclusion: One quarter to one third of the study population consistently exhibited fatigue up to 5 years post-stroke. High variability in fatigue status over time was evident, indicating individual-level heterogeneity in the longitudinal course. This was further confirmed by the identification of four latent subgroups with distinct post-stroke fatigue trajectories. Early detection of individuals at risk of an adverse fatigue trajectory and differentiated follow-up may improve outcomes for stroke survivors.
- Open Access
- 17 June 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Screening for undiagnosed obstructive sleep apnea in patients with acute stroke or TIA
Background: Obstructive sleep apnea (OSA) is a prevalent and potentially modifiable risk factor for stroke but remains underdiagnosed in clinical practice. Simple screening tools such as the STOP-Bang questionnaire and the Epworth Sleepiness Scale (ESS) may facilitate identification of individuals at risk. However, data on pre-stroke OSA-related symptoms and the utility of these screening tools in acute stroke populations remain limited. Methods: In this prospective observational study, 124 patients admitted with acute ischemic stroke or transient ischemic attack (TIA) at St. Olavs Hospital, Norway, between April 2023 and January 2026 were included. Excessive daytime sleepiness and risk of OSA prior to the index event were assessed retrospectively using the ESS and the STOP-Bang questionnaire during hospitalization, with most patients evaluated within the first three days after admission. Additional information about risk factors and stroke etiology was extracted from medical records. Results: The mean STOP-Bang score was 3.2, and 65.3% of patients were classified as having intermediate or high risk of OSA. The mean ESS score was 6.5, with 13.7% meeting criteria for excessive daytime sleepiness (ESS ≥ 11). In adjusted regression analyses, higher STOP-Bang scores were associated with higher ESS scores (β = 0.67, p = 0.004), and most patients with elevated STOP-Bang scores did not report excessive daytime sleepiness. Conclusions: A substantial proportion of patients with ischemic stroke or TIA have a previously unrecognized risk of OSA, while excessive daytime sleepiness is relatively uncommon. STOP-Bang and ESS appear to capture different aspects of sleep-disordered breathing and sleep-related symptoms. STOP-Bang identified a larger proportion of patients at risk of OSA, whereas ESS provided complementary information on subjective daytime sleepiness. Routine screening for OSA symptoms may improve identification of modifiable risk factors relevant for stroke prevention.
- 17 June 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Open AccessScreening for undiagnosed obstructive sleep apnea in patients with acute stroke or TIA
Background: Obstructive sleep apnea (OSA) is a prevalent and potentially modifiable risk factor for stroke but remains underdiagnosed in clinical practice. Simple screening tools such as the STOP-Bang questionnaire and the Epworth Sleepiness Scale (ESS) may facilitate identification of individuals at risk. However, data on pre-stroke OSA-related symptoms and the utility of these screening tools in acute stroke populations remain limited. Methods: In this prospective observational study, 124 patients admitted with acute ischemic stroke or transient ischemic attack (TIA) at St. Olavs Hospital, Norway, between April 2023 and January 2026 were included. Excessive daytime sleepiness and risk of OSA prior to the index event were assessed retrospectively using the ESS and the STOP-Bang questionnaire during hospitalization, with most patients evaluated within the first three days after admission. Additional information about risk factors and stroke etiology was extracted from medical records. Results: The mean STOP-Bang score was 3.2, and 65.3% of patients were classified as having intermediate or high risk of OSA. The mean ESS score was 6.5, with 13.7% meeting criteria for excessive daytime sleepiness (ESS ≥ 11). In adjusted regression analyses, higher STOP-Bang scores were associated with higher ESS scores (β = 0.67, p = 0.004), and most patients with elevated STOP-Bang scores did not report excessive daytime sleepiness. Conclusions: A substantial proportion of patients with ischemic stroke or TIA have a previously unrecognized risk of OSA, while excessive daytime sleepiness is relatively uncommon. STOP-Bang and ESS appear to capture different aspects of sleep-disordered breathing and sleep-related symptoms. STOP-Bang identified a larger proportion of patients at risk of OSA, whereas ESS provided complementary information on subjective daytime sleepiness. Routine screening for OSA symptoms may improve identification of modifiable risk factors relevant for stroke prevention.
- Open Access
- 2 June 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (6)
Regional inequities in acute stroke care in Norway: a national benchmark for the “stroke action plan for Europe” implementation
Introduction: The Stroke Action Plan for Europe (SAP-E) calls for equitable access to evidence-based acute stroke care, yet within-country variation remains underexplored. We mapped reperfusion capabilities, imaging resources and organisational structures across all Norwegian hospitals providing acute stroke care. Patients and methods: In 2024, we conducted a cross-sectional survey of all 50 acute stroke hospitals. Data covered reperfusion protocols, advanced imaging availability and the organisational maturity of regional stroke networks. Hospitals were categorised by their most advanced routinely available strategy: intravenous thrombolysis (IVT) within 0–4.5 h (IVT ≤ 4.5 h); IVT in wake-up stroke; IVT in both wake-up stroke and the extended window or endovascular thrombectomy (EVT) capability. Results: All hospitals providing local acute stroke treatment offered IVT ≤ 4.5 h, while 3 hospitals in South-Eastern Norway had a stroke unit but transferred all acute patients directly to a comprehensive stroke centre. Eleven hospitals (22%) provided IVT ≤ 4.5 h only, 8 (16%) implemented IVT for wake-up stroke and 28 (56%) offered IVT for both wake-up and extended-window thrombolysis. Eight hospitals (16%) were EVT-capable, unevenly distributed. CT perfusion (CTP) was available in 28 hospitals (56%), and acute MRI in 17 (34%). Regional stroke networks varied widely in structure and activity, from well-organised, funded systems to inactive or absent networks. Conclusion: Norway shows universal IVT access within 0–4.5 h but marked regional variation in advanced treatment, imaging and coordination. Strengthening and standardising regional stroke networks may be key to achieving SAP-E’s vision of equitable, high-quality care.
- 2 June 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (6)
Open AccessRegional inequities in acute stroke care in Norway: a national benchmark for the “stroke action plan for Europe” implementation
Introduction: The Stroke Action Plan for Europe (SAP-E) calls for equitable access to evidence-based acute stroke care, yet within-country variation remains underexplored. We mapped reperfusion capabilities, imaging resources and organisational structures across all Norwegian hospitals providing acute stroke care. Patients and methods: In 2024, we conducted a cross-sectional survey of all 50 acute stroke hospitals. Data covered reperfusion protocols, advanced imaging availability and the organisational maturity of regional stroke networks. Hospitals were categorised by their most advanced routinely available strategy: intravenous thrombolysis (IVT) within 0–4.5 h (IVT ≤ 4.5 h); IVT in wake-up stroke; IVT in both wake-up stroke and the extended window or endovascular thrombectomy (EVT) capability. Results: All hospitals providing local acute stroke treatment offered IVT ≤ 4.5 h, while 3 hospitals in South-Eastern Norway had a stroke unit but transferred all acute patients directly to a comprehensive stroke centre. Eleven hospitals (22%) provided IVT ≤ 4.5 h only, 8 (16%) implemented IVT for wake-up stroke and 28 (56%) offered IVT for both wake-up and extended-window thrombolysis. Eight hospitals (16%) were EVT-capable, unevenly distributed. CT perfusion (CTP) was available in 28 hospitals (56%), and acute MRI in 17 (34%). Regional stroke networks varied widely in structure and activity, from well-organised, funded systems to inactive or absent networks. Conclusion: Norway shows universal IVT access within 0–4.5 h but marked regional variation in advanced treatment, imaging and coordination. Strengthening and standardising regional stroke networks may be key to achieving SAP-E’s vision of equitable, high-quality care.
- Open Access
- 1 January 2024
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 2024 (1)
Five‐Year Risk of Cardiovascular Events after Transient Ischemic Attack: Results from a Prospective Cohort
Objectives . There are few contemporary, prospective studies reporting on the long‐term risk of stroke and other cardiovascular (CV) events after transient ischemic attack (TIA). The primary aim was to examine the risk of new CV events within 5 years after TIA. The secondary aim was to identify baseline predictors of long‐term CV events, including inflammatory biomarkers in a subgroup analysis. Materials and Methods . In a prospective, multicenter study, we enrolled 577 TIA patients between 2012 and 2014. The primary outcome was a composite of stroke, acute coronary syndrome, and CV death. We used data from the Norwegian Cardiovascular Disease Registry. In a subgroup of 112 patients, blood samples were analyzed for inflammatory biomarkers. Results . The primary outcome occurred in 108 patients (18.7%), of which 69 patients (12.0%) had a stroke. Sixty‐one (56.5%) of the events occurred during year two through five. Increasing age (HR 1.05; 95% CI, 1.03‐1.08), male sex (HR 1.82; 95% CI, 1.16‐2.85), hypertension (HR 1.67; 95% CI, 1.04‐2.67), and acute infarction on brain imaging (HR 1.84; 95% CI, 1.17‐2.91) were significant predictors for the primary outcome. In the subgroup analysis, none of the blood inflammatory biomarkers were associated with CV events. Conclusions . The risk of CV events was highest during the first year after TIA, with a lower but sustained risk throughout the follow‐up. This emphasizes the importance of both early initiation of and long‐term continuation of secondary preventive treatment after TIA. Inflammatory biomarkers are probably not important as prognostic markers of cardiovascular disease in TIA patients.
- 1 January 2024
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 2024 (1)
Open AccessFive‐Year Risk of Cardiovascular Events after Transient Ischemic Attack: Results from a Prospective Cohort
Objectives . There are few contemporary, prospective studies reporting on the long‐term risk of stroke and other cardiovascular (CV) events after transient ischemic attack (TIA). The primary aim was to examine the risk of new CV events within 5 years after TIA. The secondary aim was to identify baseline predictors of long‐term CV events, including inflammatory biomarkers in a subgroup analysis. Materials and Methods . In a prospective, multicenter study, we enrolled 577 TIA patients between 2012 and 2014. The primary outcome was a composite of stroke, acute coronary syndrome, and CV death. We used data from the Norwegian Cardiovascular Disease Registry. In a subgroup of 112 patients, blood samples were analyzed for inflammatory biomarkers. Results . The primary outcome occurred in 108 patients (18.7%), of which 69 patients (12.0%) had a stroke. Sixty‐one (56.5%) of the events occurred during year two through five. Increasing age (HR 1.05; 95% CI, 1.03‐1.08), male sex (HR 1.82; 95% CI, 1.16‐2.85), hypertension (HR 1.67; 95% CI, 1.04‐2.67), and acute infarction on brain imaging (HR 1.84; 95% CI, 1.17‐2.91) were significant predictors for the primary outcome. In the subgroup analysis, none of the blood inflammatory biomarkers were associated with CV events. Conclusions . The risk of CV events was highest during the first year after TIA, with a lower but sustained risk throughout the follow‐up. This emphasizes the importance of both early initiation of and long‐term continuation of secondary preventive treatment after TIA. Inflammatory biomarkers are probably not important as prognostic markers of cardiovascular disease in TIA patients.
- Open Access
- 25 February 2021
- Published by Wiley in Stroke Research and Treatment
- Vol. 2021, 1-8
ABCD3-I and ABCD2 Scores in a TIA Population with Low Stroke Risk
Objectives. We aimed to evaluate the ABCD3-I score and compare it with the ABCD2 score in short- (1 week) and long-term (3 months; 1 year) stroke risk prediction in our post-TIA stroke risk study, MIDNOR TIA. Materials and Methods. We performed a prospective, multicenter study in Central Norway from 2012 to 2015, enrolling 577 patients with TIA. In a subset of patients with complete data for both scores ( ), we calculated the AUC statistics of the ABCD3-I score and compared this with the ABCD2 score. A telephone follow-up and registry data were used for assessing stroke occurrence. Results. Within 1 week, 3 months, and 1 year, 1.0% ( ), 3.3% ( ), and 5.2% ( ) experienced a stroke, respectively. The AUCs for the ABCD3-I score were 0.72 (95% CI, 0.54 to 0.89) at 1 week, 0.66 (95% CI, 0.53 to 0.80) at 3 months, and 0.68 (0.95% CI, 0.56 to 0.79) at 1 year. The corresponding AUCs for the ABCD2 score were 0.55 (95% CI, 0.24 to 0.86), 0.55 (95% CI, 0.42 to 0.68), and 0.63 (95% CI, 0.50 to 0.76). Conclusions. The ABCD3-I score had limited value in a short-term prediction of subsequent stroke after TIA and did not reliably discriminate between low- and high-risk patients in a long-term follow-up. The ABCD2 score did not predict subsequent stroke accurately at any time point. Since there is a generally lower stroke risk after TIA during the last years, the benefit of these clinical risk scores and their role in TIA management seems limited. Clinical Trial Registration. This trial is registered with NCT02038725 (retrospectively registered, January 16, 2014).
- 25 February 2021
- Published by Wiley in Stroke Research and Treatment
- Vol. 2021, 1-8
Open AccessABCD3-I and ABCD2 Scores in a TIA Population with Low Stroke Risk
Objectives. We aimed to evaluate the ABCD3-I score and compare it with the ABCD2 score in short- (1 week) and long-term (3 months; 1 year) stroke risk prediction in our post-TIA stroke risk study, MIDNOR TIA. Materials and Methods. We performed a prospective, multicenter study in Central Norway from 2012 to 2015, enrolling 577 patients with TIA. In a subset of patients with complete data for both scores ( ), we calculated the AUC statistics of the ABCD3-I score and compared this with the ABCD2 score. A telephone follow-up and registry data were used for assessing stroke occurrence. Results. Within 1 week, 3 months, and 1 year, 1.0% ( ), 3.3% ( ), and 5.2% ( ) experienced a stroke, respectively. The AUCs for the ABCD3-I score were 0.72 (95% CI, 0.54 to 0.89) at 1 week, 0.66 (95% CI, 0.53 to 0.80) at 3 months, and 0.68 (0.95% CI, 0.56 to 0.79) at 1 year. The corresponding AUCs for the ABCD2 score were 0.55 (95% CI, 0.24 to 0.86), 0.55 (95% CI, 0.42 to 0.68), and 0.63 (95% CI, 0.50 to 0.76). Conclusions. The ABCD3-I score had limited value in a short-term prediction of subsequent stroke after TIA and did not reliably discriminate between low- and high-risk patients in a long-term follow-up. The ABCD2 score did not predict subsequent stroke accurately at any time point. Since there is a generally lower stroke risk after TIA during the last years, the benefit of these clinical risk scores and their role in TIA management seems limited. Clinical Trial Registration. This trial is registered with NCT02038725 (retrospectively registered, January 16, 2014).
- Open Access
- 5 March 2020
- Published by Springer Nature in Research Square
ABCD2 and ABCD3-I scores in a TIA population with low stroke risk
Background Several clinical risk scores have been developed to predict stroke risk after transient ischemic attack (TIA). We aimed to evaluate the ABCD3-I score and compare it with the ABCD2 score in short and long-term stroke risk prediction in our post TIA stroke risk study, MIDNOR TIA. Methods We performed a prospective, multicenter study in Central Norway from October, 2012, to July, 2015, enrolling 577 patients with TIA. In a subset of patients (n=305) we calculated the AUC statistics of the ABCD3-I score and compared this with the ABCD2 score at 1 week, 3 months and 1 year. To assess stroke occurrences, data obtained by telephone follow-up and registry data from the Norwegian Stroke Register was used. Results Three hundred and five patients had complete data for both ABCD3-I and ABCD2 scores. Within 1 week, 3 months and 1 year, 1.0% (n=3), 3.3% (n=10) and 5.2% (n=16) experienced a stroke, respectively. The AUCs for the ABCD3-I score were 0.72 (95% CI, 0.54 to 0.89) at 1 week (compared with ABCD2 score p =0.019), 0.66 (95% CI, 0.53 to 0.80) at 3 months ( p =0.11), and 0.68 (0.95% CI, 0.56 to 0.79) at 1 year ( p =0.39). Conclusions The ABCD3-I score had limited value in short term prediction of subsequent stroke after TIA and did not reliably discriminate between low and high-risk patients in long-term follow-up. The ABCD2 score did not predict subsequent stroke accurately at any time point. Since modern treatment regimens and a decrease in risk factors in the population have contributed to a generally lower stroke risk after TIA during the last years, the benefit of these clinical risk scores and their role in TIA management seems limited.
- 5 March 2020
- Published by Springer Nature in Research Square
Open AccessABCD2 and ABCD3-I scores in a TIA population with low stroke risk
Background Several clinical risk scores have been developed to predict stroke risk after transient ischemic attack (TIA). We aimed to evaluate the ABCD3-I score and compare it with the ABCD2 score in short and long-term stroke risk prediction in our post TIA stroke risk study, MIDNOR TIA. Methods We performed a prospective, multicenter study in Central Norway from October, 2012, to July, 2015, enrolling 577 patients with TIA. In a subset of patients (n=305) we calculated the AUC statistics of the ABCD3-I score and compared this with the ABCD2 score at 1 week, 3 months and 1 year. To assess stroke occurrences, data obtained by telephone follow-up and registry data from the Norwegian Stroke Register was used. Results Three hundred and five patients had complete data for both ABCD3-I and ABCD2 scores. Within 1 week, 3 months and 1 year, 1.0% (n=3), 3.3% (n=10) and 5.2% (n=16) experienced a stroke, respectively. The AUCs for the ABCD3-I score were 0.72 (95% CI, 0.54 to 0.89) at 1 week (compared with ABCD2 score p =0.019), 0.66 (95% CI, 0.53 to 0.80) at 3 months ( p =0.11), and 0.68 (0.95% CI, 0.56 to 0.79) at 1 year ( p =0.39). Conclusions The ABCD3-I score had limited value in short term prediction of subsequent stroke after TIA and did not reliably discriminate between low and high-risk patients in long-term follow-up. The ABCD2 score did not predict subsequent stroke accurately at any time point. Since modern treatment regimens and a decrease in risk factors in the population have contributed to a generally lower stroke risk after TIA during the last years, the benefit of these clinical risk scores and their role in TIA management seems limited.
- Open Access
- 3 January 2019
- Published by Springer Nature in BMC Neurology
- Vol. 19 (1) , 1-7
Stroke risk after transient ischemic attack in a Norwegian prospective cohort
Transient ischemic attack (TIA) is a risk factor of stroke. Modern treatment regimens and changing risk factors in the population justify new estimates of stroke risk after TIA, and evaluation of the recommended ABCD2 stroke risk score. From October, 2012, to July, 2014, we performed a prospective, multicenter study in Central Norway, enrolling patients with a TIA within the previous 2 weeks. Our aim was to assess stroke risk at 1 week, 3 months and 1 year after TIA, and to determine the predictive value of the dichotomized ABCD2 score (0–3 vs 4–7) at each time point. We used data obtained by telephone follow-up and registry data from the Norwegian Stroke Register. Five hundred and seventy-seven patients with TIA were enrolled of which 85% were examined by a stroke specialist within 24 h after symptom onset. The cumulative incidence of stroke within 1 week, 3 months and 1 year of TIA was 0.9% (95% CI, 0.37–2.0), 3.3% (95% CI, 2.1–5.1) and 5.4% (95% CI, 3.9–7.6), respectively. The accuracy of the ABCD2 score provided by c-statistics at 7 days, 3 months and 1 year was 0.62 (95% CI, 0.39–0.85), 0.62 (95% CI, 0.51–0.74) and 0.64 (95% CI, 0.54–0.75), respectively. We found a lower stroke risk after TIA than reported in earlier studies. The ABCD2 score did not reliably discriminate between low and high risk patients, suggesting that it may be less useful in populations with a low risk of stroke after TIA. Unique identifier: NCT02038725 (retrospectively registered, January 16, 2014).
- 3 January 2019
- Published by Springer Nature in BMC Neurology
- Vol. 19 (1) , 1-7
Open AccessStroke risk after transient ischemic attack in a Norwegian prospective cohort
Transient ischemic attack (TIA) is a risk factor of stroke. Modern treatment regimens and changing risk factors in the population justify new estimates of stroke risk after TIA, and evaluation of the recommended ABCD2 stroke risk score. From October, 2012, to July, 2014, we performed a prospective, multicenter study in Central Norway, enrolling patients with a TIA within the previous 2 weeks. Our aim was to assess stroke risk at 1 week, 3 months and 1 year after TIA, and to determine the predictive value of the dichotomized ABCD2 score (0–3 vs 4–7) at each time point. We used data obtained by telephone follow-up and registry data from the Norwegian Stroke Register. Five hundred and seventy-seven patients with TIA were enrolled of which 85% were examined by a stroke specialist within 24 h after symptom onset. The cumulative incidence of stroke within 1 week, 3 months and 1 year of TIA was 0.9% (95% CI, 0.37–2.0), 3.3% (95% CI, 2.1–5.1) and 5.4% (95% CI, 3.9–7.6), respectively. The accuracy of the ABCD2 score provided by c-statistics at 7 days, 3 months and 1 year was 0.62 (95% CI, 0.39–0.85), 0.62 (95% CI, 0.51–0.74) and 0.64 (95% CI, 0.54–0.75), respectively. We found a lower stroke risk after TIA than reported in earlier studies. The ABCD2 score did not reliably discriminate between low and high risk patients, suggesting that it may be less useful in populations with a low risk of stroke after TIA. Unique identifier: NCT02038725 (retrospectively registered, January 16, 2014).